The 2022 FASEB virtual Catalyst Conference on B Cells in Injury and Regeneration, March 30, 2022
FASEB J
.
2022 Aug;36(8):e22459.
doi: 10.1096/fj.202201027.
Authors
Liam J Dwyer
1
,
Ann M Stowe
2
,
Kristian Doyle
3
,
Phillip Popovich
4
,
Elizabeth Engler-Chiurazzi
5
,
Christian LeGuern
6
,
Marion S Buckwalter
7
,
Mark C Poznansky
1
,
Ruxandra F Sîrbulescu
1
8
Affiliations
1
Department of Medicine, Vaccine and Immunotherapy Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
2
Department of Neurology, University of Kentucky, Lexington, Kentucky, USA.
3
Department of Neurology, University of Arizona, Tucson, Arizona, USA.
4
Department of Neuroscience, College of Medicine, Ohio State University, Columbus, Ohio, USA.
5
Department of Neurosurgery, School of Medicine, Tulane University, New Orleans, Louisiana, USA.
6
Division of Transplantation, Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
7
Department of Neurology & Neurological Sciences, Stanford University, Stanford, California, USA.
8
Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
PMID:
35857314
PMCID:
PMC9337863
DOI:
10.1096/fj.202201027
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
MeSH terms
B-Lymphocytes*
Catalysis
Lymphocyte Count
Grants and funding
K01 MH117343/MH/NIMH NIH HHS/United States
R01 NS096091/NS/NINDS NIH HHS/United States
RF1 NS088555/NS/NINDS NIH HHS/United States